RIGScan CR49

RIGS - radioimmunoguided surgery; a 125I-labelled CR monoclonal antibody directed against the tumor-associated antigen TAG-72 for the intraoperative detection of metastatic colorectal cancer

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        RIGScan CR49: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        RIGScan CR49: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        RIGScan CR49: 1

Related Diseases

Colorectal Neoplasms (Colorectal Cancer)

01/01/2004 - "The company provided the FDA with new information related to a survival differential for patients whose colorectal cancer was evaluated with RIGScan CR49. "
01/01/2004 - "RIGScan CR49, a 125I-labelled CR monoclonal antibody directed against the tumour-associated antigen TAG-72, is undergoing development with Neoprobe for the intraoperative detection of metastatic colorectal cancer. "

Related Drugs and Biologics

1.	Antigens
2.	Monoclonal Antibodies
3.	tumor-associated antigen 72